Capital Advisors Ltd’s Champions Oncology CSBR Stock Holding History

Capital Advisors Ltd’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	48	–	–	﹤0.01%	1404
2026 Q1	$0	Hold	48	–	–	﹤0.01%	1408
2025 Q4	$0	Hold	48	–	–	﹤0.01%	1391
2025 Q3	$0	Hold	48	–	–	﹤0.01%	1390
2025 Q2	$0	Hold	48	–	–	﹤0.01%	1387
2025 Q1	$0	Hold	48	–	–	﹤0.01%	1387
2024 Q4	$0	Buy	+48	New	+$242	﹤0.01%	1411

Capital Advisors Ltd's CSBR Position: Q2 2026 in Review

Capital Advisors Ltd held its Champions Oncology (CSBR) position steady in Q2 2026 at 48 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Capital Advisors Ltd first reported a position in CSBR in Q4 2024 and has held it in 7 quarters since. 1 fund tracked by Wall St. Rank holds CSBR as of Q2 2026.

Capital Advisors Ltd held 48 shares of Champions Oncology worth $0 as of Q2 2026.
Capital Advisors Ltd left its Champions Oncology share count unchanged in Q2 2026.
Champions Oncology made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1404 holding.
Capital Advisors Ltd first reported a position in Champions Oncology in Q4 2024 and has held it in 7 quarters since.
1 fund tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.